Skip to main content
NCBI home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1985 Oct;61(5):306–310. doi: 10.1136/sti.61.5.306

Treating gonococcal infections resistant to penicillin in Bangkok: comparison of cefuroxime and spectinomycin.

A Chitwarakorn, C Ariyarit, K Panikabutra, A Buateing, J Biddle, S Thompson, S Brown
PMCID: PMC1011844  PMID: 2931346

Abstract

Gonococcal organisms have become resistant to antimicrobials throughout the world. Such resistance is common in Thailand, where 40% of gonococci produce penicillinase (PPNG strains) and over half the remainder have MICs of penicillin greater than or equal to 1 mg/l. To evaluate the effectiveness of cefuroxime against such resistant organisms, a controlled clinical trial comparing spectinomycin and cefuroxime was conducted at Bangrak Hospital, Bangkok, in 1982-3. Of 472 patients who were randomly assigned to treatment, 365 (77%) yielded positive cultures before treatment and returned for follow up evaluation three to 13 days after treatment. Of the 365 patients, 359 (98%) were cured, and no difference between the two treatment regimens was found either by the sex of the patient or by the presence of PPNG strains. The MIC of cefuroxime against all organisms was less than or equal to 1 mg/l. In vitro susceptibilities of gonococci in Bangkok have not changed appreciably during the past two years. Regimens of cefuroxime and spectinomycin are highly effective even for the relatively resistant gonococci in Bangkok. The pharmacokinetics, in vitro susceptibilities, and effectiveness of cefuroxime encourage evaluation of lower doses of the drug.

Full text

PDF
306

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acred P., Grujic P., Ryan D. M., Xerri L., Orsolini P., Erani E. In vitro activity of cefuroxime against Treponema pallidum and Neisseria gonorrhoeae. J Antimicrob Chemother. 1980 May;6(3):407–408. doi: 10.1093/jac/6.3.407. [DOI] [PubMed] [Google Scholar]
  2. Arya O. P., Rees E., Percival A., Alergant C. D., Annels E. H., Turner G. C. Epidemiology and treatment of gonorrhoea caused by penicillinase-producing strains in Liverpool. Br J Vener Dis. 1978 Feb;54(1):28–35. doi: 10.1136/sti.54.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown S., Warnnissorn T., Biddle J., Panikabutra K., Traisupa A. Antimicrobial resistance of Neisseria gonorrhoea in Bangkok: is single-drug treatment passé. Lancet. 1982 Dec 18;2(8312):1366–1368. doi: 10.1016/s0140-6736(82)91271-5. [DOI] [PubMed] [Google Scholar]
  4. Foord R. D. Cefuroxime: human pharmacokinetics.. Antimicrob Agents Chemother. 1976 May;9(5):741–747. doi: 10.1128/aac.9.5.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fowler W., Rahim G., Brown J. D. Clinical experience in the use of cefuroxime in gonorrhoea. Br J Vener Dis. 1978 Dec;54(6):400–402. doi: 10.1136/sti.54.6.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jaffe H. W., Biddle J. W., Johnson S. R., Wiesner P. J. Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976-1980. J Infect Dis. 1981 Aug;144(2):191–197. doi: 10.1093/infdis/144.2.191. [DOI] [PubMed] [Google Scholar]
  7. Jaffe H. W., Schroeter A. L., Reynolds G. H., Zaidi A. A., Martin J. E., Jr, Thayer J. D. Pharmacokinetic determinants of penicillin cure of gonococcal urethritis. Antimicrob Agents Chemother. 1979 Apr;15(4):587–591. doi: 10.1128/aac.15.4.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kellogg D. S., Jr, Turner E. M. Rapid fermentation confirmation of Neisseria gonorrhoeae. Appl Microbiol. 1973 Apr;25(4):550–552. doi: 10.1128/am.25.4.550-552.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lossick J. G., Thompson S. E., Smeltzer M. P. Comparison of cefuroxime and penicillin in the treatment of uncomplicated gonorrhea. Antimicrob Agents Chemother. 1982 Sep;22(3):409–413. doi: 10.1128/aac.22.3.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Morrison G. D., Evans A. J., Haskins H. W., Lewis N. M., Seale G. H., Mayall E., Mullinger B. M. Cefuroxime compared with penicillin for the treatment of gonorrhea. Sex Transm Dis. 1980 Oct-Dec;7(4):188–190. doi: 10.1097/00007435-198010000-00009. [DOI] [PubMed] [Google Scholar]
  11. Nayyar K. C., Michel M. F., Stolz E. Antibiotic sensitivities of gonococci isolated in Rotterdam and results of treatment with cefuroxime. Br J Vener Dis. 1980 Aug;56(4):249–251. doi: 10.1136/sti.56.4.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Panikabutra K., Ariyarit C., Chitwarakorn A., Saensanoh C. Rosoxacin in the treatment of uncomplicated gonorrhoea in men. Br J Vener Dis. 1984 Aug;60(4):231–234. doi: 10.1136/sti.60.4.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Panikabutra K., Ariyarit C., Chitwarakorn A., Warnnissorn T., Saensanoh C. Sensitivity to penicillin, thiamphenicol, kanamycin, cefoxitin and spectinomycin of penicillinase-producing Neisseria gonorrhoeae (PPNG) in Bangkok. Relation to the results of treatment. J Med Assoc Thai. 1982 Jun;65(6):316–324. [PubMed] [Google Scholar]
  14. Patamasucon P., Rettig P. J., Nelson J. D. Cefuroxime therapy of gonorrhea and coinfection with Chlamydia trachomatis in children. Pediatrics. 1981 Oct;68(4):534–538. [PubMed] [Google Scholar]
  15. Price J. D., Fluker J. L. The efficacy of cefuroxime for the treatment of acute gonorrhoea in men. Br J Vener Dis. 1978 Jun;54(3):165–167. doi: 10.1136/sti.54.3.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Thompson S. E., Washington A. E. Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiol Rev. 1983;5:96–123. doi: 10.1093/oxfordjournals.epirev.a036266. [DOI] [PubMed] [Google Scholar]
  17. Tupasi T., Crisologo L. B., Torres C. A., Calubiran O. V. Comparison of spectinomycin, cefuroxime, thiamphenicol, and penicillin G in the treatment of uncomplicated gonococcal infections in women. J Infect Dis. 1982 Apr;145(4):583–583. doi: 10.1093/infdis/145.4.583. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES